Today: 23 May 2026
AST SpaceMobile stock rebounds after Scotiabank downgrade — what’s next for ASTS
8 January 2026
1 min read

AST SpaceMobile stock rebounds after Scotiabank downgrade — what’s next for ASTS

New York, January 8, 2026, 12:43 PM EST — Regular session

  • AST SpaceMobile shares rose about 6% in midday trade after closing at $85.73 a day earlier.
  • Scotiabank cut its rating and kept a $45.60 target, pointing to valuation and execution risks.
  • Focus turns to launch cadence, customer traction and the next earnings update.

AST SpaceMobile (ASTS) shares were up 5.9% at $90.75 in midday trading on Thursday, after swinging between $85.11 and $93.96. The stock ended Wednesday at $85.73.

The bounce follows a sharp jolt in a stock that has been a standout winner. ASTS fell 12% on Wednesday after a Scotiabank downgrade reignited valuation worries, and the shares traded as low as $83.91 in the session, Barron’s reported. The stock was still up about 304% over the past 12 months, and Barron’s said the company is not expected to turn profitable until 2027.

Scotiabank analyst Andres Coello cut the shares to Underperform from Sector Perform and reiterated a $45.60 price target — the level analysts use to signal where they think a stock could trade. Coello said the shares had reached “irrational levels” and flagged questions around timing, user adoption and the cost of building out the constellation, TipRanks reported. TipRanks

AST SpaceMobile is developing satellites designed to connect directly with standard, unmodified smartphones, extending coverage where cell towers do not reach. In a late-December launch update, CEO Abel Avellan called BlueBird 6 a “breakthrough moment” and said the company was targeting 45–60 satellites in orbit by the end of 2026. Business Wire

For investors, the near-term debate is less about the concept — satellite-to-phone service is no longer theoretical — and more about execution. Any signs that carrier trials are converting into paying users, and at what price points, will matter as much as the next launch.

But the downside case is plain: a slip in launch cadence, slower-than-expected uptake, or a higher funding bill than the market is pricing could stretch timelines and keep losses wider for longer. With a stock that has run hard, that kind of delay can hit fast.

ASTS’s next scheduled milestone for many traders is its next earnings report, which Nasdaq lists as estimated for March 2, 2026, when investors will be looking for an update on cash use, deployment pace and commercial readiness.

Stock Market Today

  • NVIDIA Shares Fall 1.9% Following Analyst Downgrade Amid Insider Sales
    May 22, 2026, 6:44 PM EDT. NVIDIA (NASDAQ:NVDA) shares dropped 1.9% to $215.33 on Friday after New Street Research cut its price target slightly to $340 from $343. Trading volume was around 3% below average. Despite this, other firms like Tigress Financial and Daiwa Securities maintain optimistic views with strong buy ratings and price targets up to $400. CFO Colette Kress and EVP Ajay K. Puri sold significant stock portions, reducing their holdings by 4.62% and 9.04% respectively, amid record Q1 AI-driven demand and a new $80 billion share buyback. The stock holds a strong consensus Buy rating with a $303.27 target, reflecting continued investor interest in NVIDIA's data center growth and margin strength.

Latest articles

Peloton Shares Surge 10% as Index Funds Set to Buy

Peloton Shares Surge 10% as Index Funds Set to Buy

23 May 2026
Peloton shares closed up 10.23% at $5.71 after S&P Dow Jones Indices announced the company will join the S&P SmallCap 600 before May 27. Trading volume hit 34.9 million shares, more than double the 50-day average. The move follows Peloton’s recent report of $630.9 million in quarterly revenue and a 70% drop in net debt. U.S. markets will close May 25 for Memorial Day.
POET slips again as $400M AI optics plan triggers dilution worries

POET slips again as $400M AI optics plan triggers dilution worries

23 May 2026
POET Technologies shares fell 1.55% to $14.59 Friday on Nasdaq, despite closing a $400 million private placement with one institutional investor. The company issued 19.05 million shares and warrants, aiming to expand manufacturing capacity tenfold. Trading volume reached 33.4 million shares, down from last week’s spike. First-quarter revenue was $503,389 with a net loss of $12.3 million.
Artelo Biosciences Stock Just Whipsawed — Here’s What Traders Are Watching Now

Artelo Biosciences Stock Just Whipsawed — Here’s What Traders Are Watching Now

23 May 2026
Artelo Biosciences shares fell 10.5% to $1.19 Friday, then jumped to $2.01 in after-hours trading. The company activated a $75 million shelf registration May 19 and ended its at-the-market stock-sale agreement after raising $451,527. Artelo reported a Q1 net loss of $3 million and held $10.3 million in cash and investments as of March 31.
Lockheed Martin stock jumps on Trump’s $1.5 trillion defense-budget call after payout-ban scare
Previous Story

Lockheed Martin stock jumps on Trump’s $1.5 trillion defense-budget call after payout-ban scare

Chevron stock rises as White House pulls traders into Venezuela oil talks
Next Story

Chevron stock rises as White House pulls traders into Venezuela oil talks

Go toTop